Clinical Trials Browser

Unknown × Biliary Tract Neoplasms × Clear all

NCT06282120 2024-02-28

Efficacy and Safety of Irinotecan Liposome Injection Combined With 5-FU/LV± Immunotherapy in First-line Gemsitabine + Immunoprogressive Patients With Metastatic Biliary Tract Cancer

Gastrointestinal

Biliary Tract Neoplasms

NCT03924466 2024-02-16

VUBAR

Phase 2 Unknown

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Biliary Tract Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT06255262 2024-02-13

Durvalumab Combined With Surufatinib as Maintenance Therapy in Patients With Advanced Biliary Tract Cancer

Phase 1/2 Unknown

Gastrointestinal

Biliary Tract Neoplasms

NCT06074029 2024-02-08

Exploratory Study on the Therapeutic Effect Prediction Model of Advanced BTC Immunotherapy

Phase 1/2 Unknown

Gastrointestinal

Biliary Tract Neoplasms

NCT04329429 2023-12-20

A Study of RC48-ADC in Subjects With HER2 Overexpressed Metastatic Biliary Tract Cancer

Phase 2 Unknown

Gastrointestinal

Biliary Tract Neoplasms

NCT05520801 2023-12-19

CCGLC-002

Gastrointestinal

Biliary Tract Neoplasms, Carcinoma, Hepatocellular

NCT04450732 2023-12-05

Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors

Phase 1 Unknown

GastrointestinalThoracic

Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT05935579 2023-11-15

Durvalumab and Lenvatinib With or Without Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer

Phase 2 Unknown

Gastrointestinal

Biliary Tract Neoplasms

NCT05156788 2023-08-15

Tislelizumab（Anti PD-1), Lenvatinib and GEMOX Transformation in the Treatment of Potentially Resectable, Locally Advanced Biliary Tract Cancer

Phase 2 Unknown

Gastrointestinal

Biliary Tract Neoplasms

NCT04445532 2023-07-07

Hepatobiliary Tumors Tissue Samples Acquisition

GastrointestinalOther neoplasm

Biliary Tract Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Precancerous Conditions, Cholangiocarcinoma

NCT05743959 2023-05-22

ctDNA Detection of MRD in Predicting Postoperative Recurrence in Biliary Tract Cancers：A Multicenter Prospective Trial

Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma, Neoplasm, Residual

NCT04010071 2023-03-29

Axitinib Plus Toripalimab as Second-line Treatment in Hepatobiliary Malignant Tumors

Phase 2 Unknown

Gastrointestinal

Biliary Tract Neoplasms, Liver Neoplasms

NCT05723705 2023-03-27

LIVEROBOT

Gastrointestinal

Biliary Tract Diseases, Biliary Tract Neoplasms, Liver Diseases, Liver Neoplasms

NCT03475953 2023-03-03

REGOMUNE

Phase 1/2 Unknown

BreastEndocrineGastrointestinalGenitourinaryHead & NeckNETOther solid neoplasmSarcomaThoracic

Gastro-enteropancreatic neuroendocrine tumor, Turcot syndrome, Tertiary Lymphoid Structures, Mesothelioma, Malignant, Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Neoplasm Metastasis, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Triple Negative Breast Neoplasms

NCT05742750 2023-02-24

A Phase Ib/II Clinical Study of Camrelizumab and Apatinib Plus GP in the Treatment of Advanced Biliary Tract Cancer

Phase 1/2 Unknown

Gastrointestinal

Biliary Tract Neoplasms

NCT05237193 2023-01-17

A Prospective Study of UCAD for Diagnosing Benign or Malignant Biliary Obstruction and Follow-up

Gastrointestinal

Biliary Tract Neoplasms, Disease, Gallbladder Neoplasms, Pancreatic Neoplasms

NCT05667350 2022-12-30

AssesSment of Early-deteCtion basEd oN liquiD Biopsy in Biliary Tract Cancer (ASCEND-BTC)

Gastrointestinal

Biliary Tract Neoplasms

NCT05509478 2022-09-10

LEADER-001

Phase 2 Unknown

Gastrointestinal

Biliary Tract Neoplasms

NCT04856761 2022-08-18

A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical Resection

Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Recurrence, Cholangiocarcinoma

NCT05487443 2022-08-04

The Efficacy of Chemotherapy Combined With Immunocheckpoint Inhibitors in Advanced Biliary Malignancies

Phase 2/3 Unknown

Gastrointestinal

Biliary Tract Neoplasms

NCT04637048 2022-06-16

Observational Study on Patients With Hepatobiliary Tumors

Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT03110484 2022-06-15

Pemetrexed in Combination With Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer (BTC) Who Failed Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study

Phase 2 Unknown

Gastrointestinal

Biliary Tract Neoplasms

NCT04401709 2022-06-15

Gemcitabine+ Capecitabine Vs Capecitabine in Curatively Resected Biliary Tract Cancer

Phase 3 Unknown

Gastrointestinal

Biliary Tract Neoplasms

NCT05417230 2022-06-14

RC48-ADC Combinatioed Envolizumab in Locally Advanced or Metastatic Biliary Tract Cancer With Positive HER-2

Phase 2 Unknown

Gastrointestinal

Biliary Tract Neoplasms

NCT03898895 2022-06-02

CORRECT

Phase 2 Unknown

Gastrointestinal

Biliary Tract Neoplasms

NCT05357196 2022-05-02

PT-112 (Phosplatin's Platinum) Combine With Gemcitabine Injection for Advanced Solid Tumors

Phase 1/2 Unknown

Gastrointestinal

Biliary Tract Neoplasms

NCT05320497 2022-04-15

Transparent Cap-assisted SpyGlass for Biliary Stricture

Phase NA Unknown

Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Diseases

NCT05327582 2022-04-14

An Open-label, Phase I/II Study of PLENA Regimen in Patients With Unresectable Pancreatic Cancer or BTC

Phase 1/2 Unknown

Gastrointestinal

Biliary Tract Neoplasms, Pancreatic Neoplasms

NCT04608786 2022-01-11

A Clinical Study of PD-L1 Antibody ZKAB001 Combined With Capecitabine in Resected Biliary Tract Cancer

Phase 1 Unknown

Gastrointestinal

Biliary Tract Neoplasms

NCT04838964 2021-12-29

A Study of MRG003 in the Treatment of EGFR-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer

Phase 2 Unknown

Gastrointestinal

Biliary Tract Neoplasms

NCT05056116 2021-12-27

A Safety and Efficacy Study of Surufatinib Combination With Toripalimab in Patients With Recurrent Biliary Tract Cancer

Phase NA Unknown

Gastrointestinal

Biliary Tract Neoplasms

NCT04837508 2021-12-10

A Study of MRG002 in the Treatment of HER2-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer

Phase 2 Unknown

Gastrointestinal

Biliary Tract Neoplasms

NCT04907864 2021-06-01

MIRACLE

Phase 2 Unknown

GastrointestinalThoracic

Biliary Tract Neoplasms, Cachexia, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT04584996 2021-03-08

CIRCUS

Gastrointestinal

Biliary Tract Neoplasms, Pancreatic Neoplasms

NCT04731220 2021-01-29

A Questionnaire Survey for Biliary Tract Cancers

12,000 enrolled

Gastrointestinal

Biliary Tract Neoplasms

NCT04692051 2020-12-31

A Phase II Study for Nab-paclitaxel Plus Cisplatin vs Gemcitabine Plus Cispatin as First Line Chemotherapy in Advanced Biliary Tract Cancer

Phase 2 Unknown

Gastrointestinal

Biliary Tract Neoplasms

NCT04333927 2020-06-23

ACCORD

Phase 2 Unknown

Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT04352023 2020-04-17

Analgesic Efficacy After Pancreatobiliary Surgery: Intravenous Versus Patient-controlled Epidural

Phase 2 Unknown

Gastrointestinal

Biliary Tract Neoplasms, Pancreatic Neoplasms

NCT03873532 2020-02-13

A Trial Evaluating Surufatinib Efficacy and Safety in Biliary Tract Carcinoma Patients

Phase 2/3 Unknown

Gastrointestinal

Biliary Tract Neoplasms

NCT02943031 2019-10-18

The Effect of Individualized Precision Therapy Programs in Patients With BTC

Phase 4 Unknown

Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms

NCT03185988 2019-07-19

Anti-HER2 Therapy in Patients of HER2 Positive Metastatic Carcinoma of Digestive System

Phase 2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Biliary Tract Neoplasms, Colorectal Neoplasms

NCT04004234 2019-07-09

A Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic BTC

Phase 1/2 Unknown

Gastrointestinal

Biliary Tract Neoplasms, Neoplasm Metastasis

NCT02350686 2019-05-20

XELOX in Advanced Biliary Tract Carcinoma After Failure of Gemcitabine-based Chemotherapy

Phase 2 Unknown

Gastrointestinal

Biliary Tract Neoplasms

NCT01821248 2019-02-21

A Phase II Trial of Preoperative Chemotherapy for Biliary Tract Cancer (BTC) With Node Metastasis

Phase 2 Unknown

Gastrointestinal

Biliary Tract Neoplasms

NCT03718897 2018-10-25

Identification of Prognostic Gene Mutations in Biliary Tract Cancer Using Whole Genome Sequencing

Gastrointestinal

Biliary Tract Neoplasms

NCT03668418 2018-09-12

xenoZ

Gastrointestinal

Biliary Tract Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT03609489 2018-08-09

A Study to Investigate Apatinib Combined Capecitabine on Adjuvant Therapy of Biliary Carcinoma

Phase 2 Unknown

Gastrointestinal

Biliary Tract Neoplasms

NCT03427242 2018-02-09

Apatinib for Advanced Biliary Carcinoma

Phase 2 Unknown

Gastrointestinal

Biliary Tract Neoplasms

NCT01859728 2018-01-18

GAMBIT

Phase 2 Unknown

Gastrointestinal

Biliary Tract Neoplasms

NCT03311789 2017-10-17

Study of PD-1 Inhibitor in Combination With Gemcitabine/Cisplatin for Advancer BTCs

Phase 1/2 Unknown

Gastrointestinal

Biliary Tract Neoplasms